皮肤T细胞淋巴瘤与度普利尤单抗的应用：一个多因素且复杂的情况。 - Suppr

Cutaneous T-Cell Lymphoma and Dupilumab Use: A Multifactorial and Complex Story.

作者信息

Beylot-Barry Marie, Staumont-Salle Delphine

机构信息

Department of Dermatology, CHU de Bordeaux, Bordeaux, France; BoRdeaux Institute of onCology (BRIC), INSERM U1312, Bordeaux University, Bordeaux, France; French Study Group of Cutaneous Lymphoma (Groupe Français d'Etude des Lymphomes cutanés [GFELC]), Paris, France.

Department of Dermatology, CHU de Lille, INSERM U1286, Inflammation Translational Research Institute (INFINITE), Univ Lille, Lille, France; FRench Atopic DErmatitis Network (FRADEN) from GREAT (Groupe de Recherche sur l'Eczéma Atopique) Research Group, Nantes, France.

出版信息

J Invest Dermatol. 2025 Jan;145(1):9-11. doi: 10.1016/j.jid.2024.08.015. Epub 2024 Sep 23.

DOI:10.1016/j.jid.2024.08.015

PMID:39320302

Abstract

摘要

相似文献

Cutaneous T-Cell Lymphoma and Dupilumab Use: A Multifactorial and Complex Story.

J Invest Dermatol. 2025 Jan;145(1):9-11. doi: 10.1016/j.jid.2024.08.015. Epub 2024 Sep 23.

Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment.

J Am Acad Dermatol. 2023 Jun;88(6):e305-e306. doi: 10.1016/j.jaad.2023.01.047. Epub 2023 Feb 28.

Diagnosis of mycosis fungoides or Sézary syndrome after dupilumab use: A systematic review.

J Am Acad Dermatol. 2023 May;88(5):1164-1166. doi: 10.1016/j.jaad.2022.12.001. Epub 2022 Dec 5.

Is dupilumab use in atopic dermatitis associated with cutaneous T-cell lymphoma?

J Allergy Clin Immunol. 2025 May;155(5):1481-1482. doi: 10.1016/j.jaci.2025.02.002. Epub 2025 Feb 13.

Cutaneous T-cell lymphoma and atopy: is there an association?

Br J Dermatol. 2003 Nov;149(5):1013-7. doi: 10.1111/j.1365-2133.2003.05551.x.

Comment on "Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab".

J Am Acad Dermatol. 2022 Dec;87(6):e241-e242. doi: 10.1016/j.jaad.2022.05.069. Epub 2022 Aug 4.

Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.

Arch Dermatol. 2001 Jul;137(7):901-5.

Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).

Br J Dermatol. 2001 May;144(5):1016-23. doi: 10.1046/j.1365-2133.2001.04192.x.

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.

J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049.

Exploring the Link Between Dupilumab and Cutaneous T-Cell Lymphomas: A Systematic Review.

Dermatitis. 2025 Feb 24. doi: 10.1089/derm.2024.0486.

引用本文的文献

Cutaneous T Cell Lymphoma Following Dupilumab Therapy in Patients with Atopic Dermatitis: Clinical Review and Recommendations.

Am J Clin Dermatol. 2025 May 26. doi: 10.1007/s40257-025-00955-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cutaneous T-Cell Lymphoma and Dupilumab Use: A Multifactorial and Complex Story.

作者信息

Beylot-Barry Marie, Staumont-Salle Delphine

机构信息

出版信息

J Invest Dermatol. 2025 Jan;145(1):9-11. doi: 10.1016/j.jid.2024.08.015. Epub 2024 Sep 23.

DOI:10.1016/j.jid.2024.08.015

PMID:39320302

Abstract

摘要

相似文献

Cutaneous T-Cell Lymphoma and Dupilumab Use: A Multifactorial and Complex Story.

J Invest Dermatol. 2025 Jan;145(1):9-11. doi: 10.1016/j.jid.2024.08.015. Epub 2024 Sep 23.

Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment.

J Am Acad Dermatol. 2023 Jun;88(6):e305-e306. doi: 10.1016/j.jaad.2023.01.047. Epub 2023 Feb 28.

Diagnosis of mycosis fungoides or Sézary syndrome after dupilumab use: A systematic review.

J Am Acad Dermatol. 2023 May;88(5):1164-1166. doi: 10.1016/j.jaad.2022.12.001. Epub 2022 Dec 5.

Is dupilumab use in atopic dermatitis associated with cutaneous T-cell lymphoma?

J Allergy Clin Immunol. 2025 May;155(5):1481-1482. doi: 10.1016/j.jaci.2025.02.002. Epub 2025 Feb 13.

Cutaneous T-cell lymphoma and atopy: is there an association?

Br J Dermatol. 2003 Nov;149(5):1013-7. doi: 10.1111/j.1365-2133.2003.05551.x.

Comment on "Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab".

J Am Acad Dermatol. 2022 Dec;87(6):e241-e242. doi: 10.1016/j.jaad.2022.05.069. Epub 2022 Aug 4.

Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.

Arch Dermatol. 2001 Jul;137(7):901-5.

Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).

Br J Dermatol. 2001 May;144(5):1016-23. doi: 10.1046/j.1365-2133.2001.04192.x.

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.

J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049.

Exploring the Link Between Dupilumab and Cutaneous T-Cell Lymphomas: A Systematic Review.

Dermatitis. 2025 Feb 24. doi: 10.1089/derm.2024.0486.

引用本文的文献

Cutaneous T Cell Lymphoma Following Dupilumab Therapy in Patients with Atopic Dermatitis: Clinical Review and Recommendations.

Am J Clin Dermatol. 2025 May 26. doi: 10.1007/s40257-025-00955-7.

Cutaneous T-Cell Lymphoma and Dupilumab Use: A Multifactorial and Complex Story.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Cutaneous T-Cell Lymphoma and Dupilumab Use: A Multifactorial and Complex Story.

作者信息

机构信息

出版信息

相似文献

引用本文的文献